Form 4: Haemonetics Corp CEO Christopher Simon Reports Stock Disposals for Tax Obligations
SEC Form 4
Christopher Simon, President & CEO of Haemonetics Corp, reported disposing of shares to cover tax obligations related to vesting restricted stock units.
Summary
- Christopher Simon, the President & CEO of Haemonetics Corp, filed a Form 4 detailing changes in beneficial ownership.
- On May 15, 2025, 2,391 shares of common stock were disposed of at a price of $69.38 per share to cover tax obligations.
- On May 16, 2025, 7,089 shares of common stock were disposed of at a price of $70.31 per share to cover tax obligations.
- Following these transactions, Mr. Simon beneficially owns 313,707 shares of Haemonetics Corp.
- This number includes unvested RSUs and 349 shares acquired under the Issuer's 2007 Employee Stock Purchase Plan on April 30, 2025.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to routine stock disposals for tax obligations, which is a normal part of executive compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Disposals for tax obligations are common when restricted stock units vest.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in insider ownership, but the disposals are for tax purposes and not indicative of a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| April 30, 2025 | Reporting person acquired 349 shares under the Issuer's 2007 Employee Stock Purchase Plan (as amended). |
| May 15, 2025 | 2,391 shares of common stock disposed of for tax obligations at $69.38 per share. |
| May 16, 2025 | 7,089 shares of common stock disposed of for tax obligations at $70.31 per share. |
| May 19, 2025 | Date of Form 4 signature. |
Keywords
Form 4, Beneficial Ownership, Haemonetics Corp, Christopher Simon, Stock Disposal, Tax Obligations, RSUs, Employee Stock Purchase Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.